U.S. Wireless Telecom Stock News

Recent performance snapshot for Cheniere Energy Partners (CQP) Cheniere Energy Partners (CQP) has drawn investor attention after a mixed stretch in its liquefied natural gas operations, with annual revenue of US$10.76b alongside net income of US$2.50b and moderate year on year growth figures. See our latest analysis for Cheniere Energy Partners. At a share price of US$62.73, Cheniere Energy Partners has seen a 16.17% year to date share price return and a 10.29% total shareholder return over...

If you are wondering whether Sanmina's share price still offers value or if the easy gains are behind it, the starting point is to look closely at what the current price implies about the business. At a last close of US$188.08, Sanmina has recorded returns of 7.2% over the past week, 43.7% over the past month, 18.1% year to date and 133.0% over the past year, which naturally raises questions about growth potential and how much risk is now priced in. This article was triggered to provide...

Earnings shock and shifting freight conditions Marten Transport (MRTN) opened the quarter with a weaker earnings print, as first quarter 2026 sales and net income both came in below the prior year while freight demand, winter weather and diesel costs weighed on results. At the same time, management pointed to freight market changes driven by tighter regulatory enforcement that are removing noncompliant drivers. This is a backdrop investors may watch closely as they assess Marten Transport...

Brixmor Property Group Inc. has reported its first-quarter 2026 results, with revenue of US$354.82 million and net income of US$127.75 million, alongside basic earnings per share from continuing operations of US$0.42, all above the prior year’s levels. The company also delivered funds from operations that exceeded analyst expectations, raised its 2026 Nareit FFO and same-property NOI outlook, and declared a quarterly cash dividend, underscoring stronger leasing activity and operational...

Investors may be wondering whether Cencora, at around US$310, is still fairly priced after a strong run in recent years, or whether the value case is starting to look stretched. The stock has recently seen a 4.0% decline over the past week and is 0.7% lower over the last 30 days, although it shows returns of 8.6% over 1 year, 90.9% over 3 years, and 164.2% over 5 years. Recent coverage has focused on Cencora's role in healthcare distribution and broader sector trends that keep attention on...

Recent performance snapshot Gold.com (GOLD) has drawn fresh attention after recent trading, with the share price closing at $47.21. For context, the stock shows a 0.4% move over the past day and a 2.9% decline over the past week. See our latest analysis for Gold.com. The recent 1 month share price return of 19.8% and year to date share price return of 35.8% contrast with a 7.7% 3 month decline, while the 1 year total shareholder return of 97.8% points to strong longer term gains despite short...

In the past week, The Bancorp, Inc. reported first-quarter 2026 results showing net income of US$60.07 million and diluted EPS of US$1.41, alongside lower net charge-offs and the completion of a US$50.00 million buyback covering 843,061 shares. Management also reaffirmed 2026 EPS guidance of US$5.90, introduced a 2027 EPS range of US$8.10–US$8.30, and highlighted rapid growth in fintech-related credit sponsorship balances to US$1.65 billion, reflecting a continued shift toward higher-return,...

First quarter earnings trigger fresh focus on Stepan Stepan (SCL) is drawing attention after first quarter 2026 results showed sales of US$604.51 million alongside a net loss of US$41.41 million, compared with net income in the prior year period. See our latest analysis for Stepan. The first quarter loss comes after a period where momentum has softened, with an 11.66% year to date share price return and a 12.74% one year total shareholder return set against a 37.39% three year total...

The United States market remained flat over the last week but has experienced a significant 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential gains while aligning with projected growth trends.

Pinnacle West Capital Corporation recently declared a quarterly dividend of US$0.9100 per share, payable on June 1, 2026, to shareholders of record as of the May 4, 2026 ex-dividend and record date. Alongside this dividend affirmation, analysts are highlighting a positive Earnings ESP and a neutral Zacks Rank, pointing to rising expectations around the upcoming earnings release. Next, we’ll examine how optimism around a potential earnings beat may influence Pinnacle West Capital’s existing...

In the last week, the market has stayed flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability within a rapidly evolving sector.

Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the shares around $22.23, with a mixed return profile across the past week, month and past 3 months. See our latest analysis for Kestra Medical Technologies. The recent 14.23% 1 month share price return contrasts with weaker year to date share price performance of 8.86% and a 1 year total shareholder return of 11.50%. This suggests short term momentum has picked up while longer term returns remain under...

ZTO Express (Cayman) (ZTO) stock has drawn fresh attention after recent trading, with shares last closing at $25.42. Readers are weighing this move against its performance over the past month and the previous three months. See our latest analysis for ZTO Express (Cayman). That 1 month share price return of 5.65% builds on a 90 day share price return of 17.25%, while the 1 year total shareholder return of 36.83% suggests momentum has been gaining rather than fading. If recent moves in ZTO have...

Oppenheimer Holdings Inc. disclosed that its main subsidiary, Oppenheimer & Co. Inc., agreed to a US$70,000,000 class-action settlement over its FDIC-insured cash sweep program, subject to final court approval and booked as a first-quarter 2026 charge. The settlement caps a case where plaintiffs had indicated they might seek more than US$440,000,000 in damages, sharply reducing legal uncertainty while leaving Oppenheimer without any admission of wrongdoing. We will now examine how...

Telephone and Data Systems (TDS) is in the spotlight after selling its UScellular wireless operations for US$4.4b, pivoting toward towers, long term leasing with T-Mobile, and fiber to the home broadband services. See our latest analysis for Telephone and Data Systems. The share price reaction around the UScellular sale and leadership changes has been mixed, with a 5.22% 1 month share price return and a 7.48% year to date share price return, while the 3 year total shareholder return is very...

The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

Earlier in April 2026, HubSpot used its Spring Spotlight event to launch HubSpot AEO, expand its Prospecting and Customer Agents, and introduce Smart Deal Progression across marketing, sales, and support. By tying these AI agents directly to customer CRM data and charging usage-based fees, HubSpot is trying to defend its position as AI-native competitors pressure pricing and feature parity. Next, we'll examine how HubSpot's AI-powered AEO tool could reshape its investment narrative and...

In late March, Wedbush downgraded Burford Capital to Neutral after a U.S. Appeals Court decision in the YPF case prompted the company to flag that fair value marks could affect its net worth requirements and access to debt financing. Deutsche Bank, however, maintained a positive stance on Burford’s long-term prospects, highlighting that legal and balance sheet uncertainties around YPF are now central to how investors assess the business. We’ll now look at how heightened concern over net...

In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...

Camtek (CAMT) has drawn fresh attention after recent trading, with the share price at $190.92, a total return of about 195% over the past year, and annual revenue of roughly $496.1 million. See our latest analysis for Camtek. The recent pullback, with a 1 day share price return of about a 6% decline to US$190.92, comes after strong momentum, including a 30 day share price return of 24.5% and a very large 3 year total shareholder return. This suggests sentiment has shifted quickly but longer...

The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.

Veradermics (NYSE:MANE) reported positive topline data from its pivotal Phase 2/3 trial of VDPHL01, an investigational non-hormonal oral treatment for pattern hair loss. The company framed VDPHL01 as a potential first in class oral option that could lead to the first FDA approval for a non-hormonal hair loss pill in nearly 30 years. Following the clinical update, Veradermics launched a proposed public offering tied to this stage of clinical and corporate progress. Veradermics focuses on...

In the last week, the United States market has stayed flat, yet it is up 30% over the past year with earnings expected to grow by 16% per annum over the next few years. In such a dynamic environment, reliable dividend stocks with yields of at least 3.1% can offer investors a steady income stream and potential for long-term growth.

Why Columbia Sportswear (COLM) is on investors’ radar today Columbia Sportswear (COLM) is back in focus after recent share price moves, with the stock showing mixed short term performance while longer term returns remain under pressure, prompting fresh questions about valuation and fundamentals. See our latest analysis for Columbia Sportswear. At a share price of $61.08, Columbia Sportswear has a 30 day share price return of 11.85% and a 90 day share price return of 13.36%. However, the 5...